The team's analysis also examines why blood-thinning medications aren't effectively preventing the clots. 

Researchers recommended intermittent fasting for 12 to 16 hours at a time. 

The authors did emphasize that they were not ruling on the overall “clinical efficacy” of hydroxychloroquine with this research. 

The American College of Cardiology Summit on Technology Advances in Coronary Computed Tomography Angiography shared its assessment in a new report. 

The role of ACE inhibitors and ARBs in the treatment of COVID-19 has been a key topic for researchers since the pandemic began. This latest research represents a significant update for clinicians. 

The study's authors urged physicians to use caution when prescribing these medications for "off-label indications." 

Researchers focused on long-term heart and lung damage among recovered COVID-19 patients, turning to lung function tests, CT imaging and echocardiograms. 

Prior use of ACE inhibitors or ARBs, however, was not associated with the same changes. 

Willerson's research spanned decades and included topics such as unstable atherosclerotic plaques and human stem cells. He is remembered for his passion and the impact he made on those around him. 

“The findings of this study will influence shared decision-making between chronic kidney disease patients and the heart team,” one specialist observed.